Suarez-Almazor, Maria; Pundole, Xerxes; Abdel-Wahab, Noha; Johnson, Douglas; Gupta, Dipti; Glezerman, Ilya; Cooksley, Tim; Anderson, Ronald; Blidner, Ada Gabriela; Choi, Jennifer; Dougan, Michael; Ginex, Pamela; Girotra, Monica; Shannon, Vickie R.; Rapoport, Bernardo Leon
(Springer, 2020-12)
Immune checkpoint inhibitors (ICIs) have emerged as the newest pillar of cancer treatment. Immune-mediated toxicities, stemming from increased activity within the T cell lineage, range from asymptomatic or mild complications ...
